长寿型工程酵母构建及其高效催化合成熊去氧胆酸的研究OA
Construction of a long-lived engineered yeast and its efficient catalytic synthesis of ursodeoxycholic acid
熊去氧胆酸(UDCA)是临床治疗肝胆疾病的一线药物.基于全细胞催化的鹅去氧胆酸(CDCA)生物转化技术为其绿色制造提供了重要替代路径.然而,在发酵过程中,细胞衰老及CDCA 胁迫导致催化体系稳定性下降,严重制约了该技术的工业化应用.该研究以延长细胞时序寿命为切入点,系统评估了过表达时序寿命调控因子血红素激活蛋白 4 基因(HAP4)对全细胞催化性能的影响.研究发现,在 CDCA 胁迫条件下发酵 8 d,过表达 HAP4 后细胞存活率较野生型提高了 4.5 倍,表明过表达 HAP4 显著延长了酿酒酵母的时序寿命.进一步通过筛选高效基因元件,获得了高效的催化模块组合:大肠杆菌来源的7α-羟基类固醇脱氢酶(7α-HSDH)和扭链瘤胃球菌来源的 RT-7β-HSDH,将二者在酿酒酵母 BY4742 中进行组装,获得了高效 CDCA 全细胞催化菌株 BY-RT,其 UDCA 转化率达到 96.0%.在此基础上进一步过表达 HAP4,获得长寿型工程菌株 BY-RT-HAP4.经过 20 d 的摇瓶发酵实验后,BY-RT-HAP4 的催化效率仍能保持在 44.4%,比 BY-RT 提高了 14.8 倍.最后,在5 L 发酵罐中模拟工业化培养条件,系统评估强化 HAP4 表达对 UDCA 全细胞催化性能的影响.当面临更大的环境压力与更高的底物浓度胁迫时,BY-RT-HAP4 在发酵末期的催化效率仍比 BY-RT 提高了 13.4%.研究表明,强化 HAP4 表达能够有效维持细胞活性与代谢稳态,显著提升UDCA的全细胞转化效率,为UDCA绿色高效生物制造提供了新的代谢工程策略和理论依据.
Ursodeoxycholic acid(UDCA)is a first-line drug for the clinical treatment of hepatobiliary diseases.The bioconversion of chenodeoxycholic acid(CDCA)based on whole-cell catalysis provides an important alternative approach for its green production.However,during fermentation,cellular aging and CDCA-induced stress lead to decreased stability of the catalytic system,which severely restricts its industrial application.This study took the extension of cellular chronological lifespan as the entry point,and systematically evaluated the effects of overexpressing the chronological lifespan regulatory factor heme activator protein 4 gene(HAP4)on whole-cell catalytic performance.The results showed that,under CDCA stress conditions after 8 days of fermentation,the survival rate of cells overexpressing HAP4 was 4.5-fold higher than that of the wild type,indicating that HAP4 overexpression significantly prolonged the CLS of Saccharomyces cerevisiae.Furthermore,by screening efficient genetic elements,an efficient catalytic module was obtained,consisting of 7α-hydroxysteroid dehydrogenase(7α-HSDH)from Escherichia coli and RT-7β-hydroxysteroid dehydrogenase(RT-7β-HSDH)from Ruminococcus torques.These enzymes were assembled in S.cerevisiae BY4742 to construct an efficient CDCA whole-cell catalytic strain,BY-RT,which achieved a UDCA conversion rate of 96.0%.On this basis,HAP4 was further overexpressed to obtain a long-lived engineered strain,BY-RT-HAP4.After 20 days of shake-flask fermentation,the catalytic efficiency of BY-RT-HAP4 remained at 44.4%,representing a 14.8-fold increase compared with BY-RT.Finally,industrial fermentation conditions were simulated in a 5 L bioreactor to systematically evaluate the effect of enhanced HAP4 expression on UDCA whole-cell catalytic performance.Under conditions of greater environmental stress and higher substrate concentration stress,the catalytic efficiency of BY-RT-HAP4 at the end of fermentation was still 13.4%higher than that of BY-RT.These results demonstrate that enhanced HAP4 expression can effectively maintain cellular activity and metabolic homeostasis,significantly improve the whole-cell conversion efficiency of UDCA,and provide a new metabolic engineering strategy and theoretical basis for the green and efficient biosynthesis of UDCA.
马晓晨;李紫薇;杨婷婷;李畏娴;孟欣;郭秋均;张学礼;王冬;戴住波
天津科技大学 生物工程学院,天津 300457||中国科学院 天津工业生物技术研究所,天津 300308||国家合成生物技术创新中心,天津 300308中国科学院 天津工业生物技术研究所,天津 300308||国家合成生物技术创新中心,天津 300308中国科学院 天津工业生物技术研究所,天津 300308||国家合成生物技术创新中心,天津 300308中国科学院 天津工业生物技术研究所,天津 300308||国家合成生物技术创新中心,天津 300308天津科技大学 生物工程学院,天津 300457中国中医科学院 广安门医院,北京 100053中国科学院 天津工业生物技术研究所,天津 300308||国家合成生物技术创新中心,天津 300308中国科学院 天津工业生物技术研究所,天津 300308||国家合成生物技术创新中心,天津 300308中国科学院 天津工业生物技术研究所,天津 300308||国家合成生物技术创新中心,天津 300308
全细胞催化时序寿命鹅去氧胆酸熊去氧胆酸HAP4
whole-cell biocatalysischronological lifespanchenodeoxycholic acidursodeoxycholic acidHAP4
《中国中药杂志》 2026 (14)
3989-3996,8
国家重点研发计划项目(2022YFC2105000)中央本级重大增减支项目(2060302)
评论